Related Experiment Video
Updated: Dec 11, 2025

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
[Acute viral bronchiolitis and wheezy bronchitis in children]
Christina Schorlemer1, Ernst Eber1
1Klinische Abteilung für Pädiatrische Pulmonologie und Allergologie, Univ.-Klinik für Kinder- und Jugendheilkunde, Medizinische Universität Graz, Auenbruggerplatz 34/2, 8036 Graz, Österreich.
Acute viral bronchiolitis and wheezy bronchitis are common in young children, often caused by respiratory syncytial virus. Diagnosis relies on history and physical exam, with supportive care recommended over routine medications.
Area of Science:
- Pediatrics
- Infectious Diseases
- Respiratory Medicine
Context:
- Acute viral bronchiolitis and wheezy bronchitis are highly prevalent in infants and preschool children.
- Respiratory syncytial virus (RSV) and rhinoviruses are primary causative agents.
- Risk factors for severe disease include prematurity, environmental tobacco smoke, and immune system disorders.
Purpose:
- To review the diagnosis and management of acute viral bronchiolitis and wheezy bronchitis in pediatric populations.
- To differentiate between recommended and non-recommended therapeutic interventions.
- To discuss the role of pharmacologic treatments in preventing long-term respiratory conditions.
Summary:
- Diagnosis is typically achieved through clinical history and physical examination, negating the routine need for chest X-rays or laboratory tests.
- Supportive care, including adequate oxygenation and hydration, is the cornerstone of acute bronchiolitis management.
- Short-acting beta-2 agonists are indicated for wheezy bronchitis, with inhaled corticosteroids considered for recurrent or severe cases; however, no pharmacologic treatment prevents asthma development.
Impact:
- Provides evidence-based guidance for clinicians managing common pediatric respiratory infections.
- Emphasizes the importance of supportive care and judicious use of medications.
- Clarifies the limitations of current pharmacologic interventions in preventing the progression to asthma.
More Related Videos
Related Concept Videos
Pulmonary Cycle: Exhalation
Asthma-I: Introduction
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

